For nonadherent patients, individualized testing does not increase colorectal cancer screening rates
the ONA take:
According to a study published in the journal Annals of Internal Medicine, researchers have found that patients who know their individual risk for colorectal cancer is not sufficient to convince previously nonadherent patients to be screened for the disease.
For the study, the researchers identified 783 participants at average risk for colorectal cancer who had not been adherent to screening at the time of entering the study. Participants were randomized to receive either usual care or individualized genetic and environmental risk assessment (GERA) of colorectal cancer susceptibility.
GERA evaluates methylenetetrahydrofolate reductase polymorphisms and serum folate levels. Patients that received GERA were informed whether they were at an average or elevated risk for developing colorectal cancer.
The researchers found no statistically significant difference in overall screening rates between the two groups. In addition, there was no significant different in screening rates between those identified by GERA as having average risk and those having elevated risk. The findings suggest that personalized GERA does not increase the number of nonadherent patients who receive screenings.
Patients who know individual risk are not sufficient to convince previously nonadherent patients.
Knowing their individual risk for disease is not enough to pursuade previously nonadherent patients to undergo recommended colorectal cancer (CRC) screenings, according to a randomized, controlled trial being published in Annals of Internal Medicine. CRC is the second leading cause of cancer death in the United States. Increasing screening rates is imperative because screening can reduce disease incidence and mortality.
Researchers hypothesized that providing average-risk patients with a personalized genetic and environmental risk assessment (GERA) would increase CRC screening uptake compared with usual care. About 780 participants at average risk for CRC who were not adherent to screening at the time of the study were randomly assigned to usual care or GERA.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|